BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 15 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 15 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 15 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 16 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 16 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 17 hours ago Atmus Welcomes Heath Sharp to Board of Directors 19 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 19 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 15 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 15 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 15 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 16 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 16 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 17 hours ago Atmus Welcomes Heath Sharp to Board of Directors 19 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 19 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT
ALT

All ALT Content

2 articles, transcripts, and reports

Analysis

Is Altimmune (ALT) stock a buy right now?

A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment…

3 min read